Bailard Portfolio holdings
Bailard is an independent wealth and asset manager, started in 1969 by three alumni of the Stanford Graduate School of Business. In 1979 it brought out one of the earliest US mutual funds that invests in foreign stocks, and in 1990 it began serving pension funds, endowments and foundations and introduced a commercial real estate fund. Its equity portfolios mix model-based research, company analysis and judgment, and for clients who want their investments to reflect social and environmental values it builds sustainable and impact portfolios. It was formerly called Bailard, Biehl & Kaiser, and is a wholly owned subsidiary of the privately owned BB&K Holdings; Sonya Mughal became chief executive in 2021 after 27 years at the firm.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 Value ETF
IWN
|
+$58.4M |
| 2 |
State Street SPDR Bloomberg Investment Grade Floating Rate ETF
FLRN
|
+$8.89M |
| 3 |
Teva Pharmaceutical Industries Limited
TEVA
|
+$8.58M |
| 4 |
Check Point Software Technologies
CHKP
|
+$7.27M |
| 5 |
State Street SPDR Nuveen ICE Municipal Bond ETF
TFI
|
+$5.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
|
+$58.9M |
| 2 |
State Street SPDR Nuveen ICE Short Term Municipal Bond ETF
SHM
|
+$11.2M |
| 3 |
Credicorp
BAP
|
+$8.21M |
| 4 |
Alibaba
BABA
|
+$5.31M |
| 5 |
Schwab US Large- Cap ETF
SCHX
|
+$5.21M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 48.88% |
| 2 | Technology | 15.62% |
| 3 | Healthcare | 7.25% |
| 4 | Financials | 6.27% |
| 5 | Communication Services | 5.69% |
Similar funds
Bailard's Q3 2018 Portfolio in Review
As of Q3 2018, Bailard held 586 positions worth $1.71B, up 1.9% from $1.68B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Bailard's Q3 2018 filing shows 76 new, 162 increased, 181 reduced and 60 closed positions. Its largest new stake was Teva Pharmaceutical Industries Limited: 369,700 shares worth $7.96M. The largest sale was PIMCO Enhanced Short Maturity Active Exchange-Traded Fund, an estimated $58.9M.
By sector, the portfolio is most concentrated in Miscellaneous at 49% of assets, down from 50% a quarter earlier, followed by Technology and Healthcare.
- Bailard's largest Q3 2018 buy was Teva Pharmaceutical Industries Limited: 369,700 shares worth $7.96M.
- Bailard added most to iShares Russell 2000 Value ETF in Q3 2018, an estimated $58.4M increase.
- Bailard's biggest Q3 2018 reduction was PIMCO Enhanced Short Maturity Active Exchange-Traded Fund, cutting an estimated $58.9M.
- Bailard fully exited Mercado Libre in Q3 2018, selling an estimated $3.89M.
- Bailard's ten largest holdings make up 33% of its $1.71B portfolio in Q3 2018.
- Bailard opened 76 new positions and closed 60 in Q3 2018.
- Bailard's portfolio value rose 1.9% quarter-over-quarter to $1.71B.
Based on Bailard's 13F filing for Q3 2018, filed 13 Nov 2018.